A central mandate of the ADRC is to understand the pathophysiologic processes that underlie dementia. Nonetheless, the physical basis of cognitive and psychiatric symptoms in Alzheimer's disease (AD) remains uncertain, and there is a gap in our knowledge about age related changes in nondemented elderly. The Massachusetts ADRC has been collecting brain tissue from individuals who have been longitudinally clinically studied for 10 years. We have accumulated enough material to finally begin to construct a detailed model of clinical-pathological relationships in AD. We now propose to expand studies we recently initiated aimed at uncovering the temporal sequence of neuropathological changes in AD, and at answering whether or not neurofibrillary tangles (NFT), senile plaques (SP), neuronal loss an/or synaptic loss correlate with the clinical symptoms of AD. We will study AD patients, Down syndrome patients, and nondemented elderly individuals. Our results so far have led to several unexpected findings: SP do not correlate at all with duration or severity of dementia. We hypothesize that SP are in a dynamic equilibrium, both forming and resolving during the course of the disease. We suggest that A beta may be mobilized from the neuropil by ApoE or other potential A beta chaperone proteins. We will explore the recently reported association between sporadic AD and the ApoE-E4 allele by studying the influence of ApoE genotype on neuropathological phenotype. We also postulate that interactions of SP with inflammatory or proteolytic processes could lead to turnover of SP, and potentially to loss of neurons and synapses as well. We will examine SP turnover using a novel strategy based on the nonenzymatic accumulation of advanced glycosylation end products on long lived proteins. We and others find that NFT number in high order association cortices correlate with global measures of dementia. Synaptic loss has also been suggested as a physical substrate of dementia. We find that estimates of neuronal loss in high order association cortex correlate with clinical condition remarkably well. Surprisingly, however, our preliminary data suggest that neuronal loss far outstrips NFT formation, and that NFT formation may account for only a small minority of neuronal loss in the neocortex. Finally, neuropathological variables will be combined with the clinical data base. This will allow us to examine clinical and neuropathological heterogeneity, and to test hypotheses about clinical-pathological correlations. Looking to the future, we expect that additional candidate genes that are risk factors for or causative of AD will emerge, and the tissue samples and data developed in this project will be an ideal resource for determining clinical-pathological and genotype- phenotype correlations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005134-11
Application #
3745730
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
11
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Harvard University
Department
Type
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Jacobs, Heidi I L; Hedden, Trey; Schultz, Aaron P et al. (2018) Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals. Nat Neurosci 21:424-431
Rieckmann, Anna; Johnson, Keith A; Sperling, Reisa A et al. (2018) Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging. Proc Natl Acad Sci U S A 115:10160-10165
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Martinez-Ramirez, Sergi; van Rooden, Sanneke; Charidimou, Andreas et al. (2018) Perivascular Spaces Volume in Sporadic and Hereditary (Dutch-Type) Cerebral Amyloid Angiopathy. Stroke 49:1913-1919
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Putcha, Deepti; McGinnis, Scott M; Brickhouse, Michael et al. (2018) Executive dysfunction contributes to verbal encoding and retrieval deficits in posterior cortical atrophy. Cortex 106:36-46
Qian, Jing; Chiou, Sy Han; Maye, Jacqueline E et al. (2018) Threshold regression to accommodate a censored covariate. Biometrics :
Mordes, Daniel A; Prudencio, Mercedes; Goodman, Lindsey D et al. (2018) Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients. Acta Neuropathol Commun 6:55
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Makaretz, Sara J; Quimby, Megan; Collins, Jessica et al. (2018) Flortaucipir tau PET imaging in semantic variant primary progressive aphasia. J Neurol Neurosurg Psychiatry 89:1024-1031

Showing the most recent 10 out of 966 publications